Top Stories
-
Among young adults who smoke cigarettes, vaping may increase daily cigarette smoking and deter quitting, a new study by Columbia psychiatrists has found.
Topic
-
A new generation of transgender youth and adults is rejecting the traditional binary model of gender identity, says Walter Bockting of Columbia’s Gender Identity Program.
-
A new study suggests that antidepressants may control symptoms of schizophrenia better than other types of psychiatric drugs when combined with antipsychotic drugs.
Topic
-
A new study of elderly Hispanics found that hearing loss increased the risk of depression symptoms.
Topic
Latest News
- October 31, 2017
From 2005 to 2015, depression rose significantly among Americans age 12 and older, according to researchers at the Mailman School of Public Health and CUNY.
Topic
- September 26, 2017
Marijuana use significantly increases the risk of developing an opioid use disorder, a new study from Columbia Psychiatry has found.
Topic
- September 20, 2017
Suicide attempts among U.S. adults are on the rise, especially among young adults between 21 and 34 years of age, a new CUMC study has found.
Topic
- September 6, 2017
Place cells in the brains of mice with a disorder similar to schizophrenia do not adapt to changing environments, impairing memory.
Topic
- July 17, 2017
A study showed that violent thoughts and recent violent behavior may predict future violence in people at high risk for psychosis.
Topic
- June 14, 2017
Prenatal exposure to maternal fever during the second trimester raised odds of autism spectrum disorder by 40 percent, Mailman researchers found.
Topic
- June 9, 2017
For patients with schizophrenia, antipsychotic medications do not have negative long-term effects on outcomes or the brain, according to a panel of experts.
Topic
- June 5, 2017
Chronic pain coupled with a psychiatric disorder is a pressing issue that should be considered when providing treatment, say Mailman researchers.
Topic
- May 19, 2017
Neurosurgeon Sameer Sheth uses deep brain stimulation to treat depression in patients who have not been helped with other therapies.
Topic
- May 12, 2017
Opioid receptors in the brain are responsible for the antidepressant effects of tianeptine, a new study from CUMC researchers has found.
Topic
